Evidence map›Paper›PMID 8057455›Full record

ArticleJournal of virology1994

The herpes simplex virus type 1 major capsid protein (VP5-UL19) promoter contains two cis-acting elements influencing late expression.

C J Huang, E K Wagner

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

C J HuangDepartment of Molecular Biology and Biochemistry, University of California, Irvine 92717.
E K Wagner
University of California, Irvine · US

Funding

CONTROL OF VIRAL RNA SYNTHESIS IN HERPESVIRUS INFECTIONR01CA011861 · NCI · UNIVERSITY OF CALIFORNIA IRVINE · PI OSBORNE, TIMOTHY F · 1985 to 2005
$1.9M
CONTROL OF VIRAL RNA SYNTHESIS IN HERPESVIRUS INFECTIONR37CA011861 · NCI · UNIVERSITY OF CALIFORNIA IRVINE · PI WAGNER, EDWARD K · 1988 to 1995
–
NCI NIH HHS CA11861
6 · The paper itself

Abstract

The herpes simplex virus type 1 (HSV-1) major capsid protein VP5 gene (UL19) is expressed with beta gamma (gamma 1 [leaky late]) kinetics. We have previously described the construction of recombinant HSV-1 in which the VP5 promoter was engineered to control the expression of the bacterial beta-galactosidase gene as a reporter (C.-J. Huang, S. A. Goodart, M. K. Rice, J. F. Guzowski, and E. K. Wagner, J. Virol. 67:5109-5116, 1993). Here we describe further mutational analysis in recombinant viruses. We have precisely defined the boundaries of the VP5 promoter and identified two regions important for both the level and the kinetics of expression. The 5' boundary was located at -48 relative to the initiation site of transcription by analyzing a series of nested deletions in the upstream sequence, and although a number of cis-acting sites influencing transient expression have been identified upstream of this point, these sites have no role in promoter activity during productive infection. Deletion of an Sp1-binding site located between -48 and the TATA box at -30 greatly reduced VP5 promoter activity late but not early after infection. A cis-acting element whose sequence resembles the human immunodeficiency virus type 1 initiator was located between -2 and +10 in the VP5 sequence by characterizing a series of deletions and site-directed block mutations downstream the TATA box. This element defines the 3' limit of the VP5 promoter, and like the upstream element, disruption of this element also inhibited promoter activity late in the productive cycle.

Indexed as

Gene Expression Regulation, ViralBase SequenceBinding SitesCapsidCapsid ProteinsConsensus SequenceDNA Mutational AnalysisHerpesvirus 1, HumanMolecular Sequence DataMutagenesis, Site-DirectedPromoter Regions, GeneticRNA, MessengerSequence DeletionSp1 Transcription FactorTranscription, GeneticViral ProteinsCapsid ProteinsRNA, MessengerSp1 Transcription FactorUL19 protein, simplexvirusViral ProteinsVP5 protein, Herpes simplex virus type 1

Identifiers

PMID8057455
PMCPMC236977
OpenAlexW1555757601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.